Factors impacting vaccine hesitancy toward Coronavirus disease-19 (COVID-19) vaccination in Brooklyn, New York.
COVID-19
COVID-19 vaccine
New York
seasonal influenza vaccine
vaccine hesitancy
Journal
Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652
Informations de publication
Date de publication:
02 Nov 2021
02 Nov 2021
Historique:
pubmed:
10
7
2021
medline:
15
1
2022
entrez:
9
7
2021
Statut:
ppublish
Résumé
The Coronavirus disease-2019 (COVID-19) pandemic led to the development of several candidate vaccines. However, current research suggests that the potential of successful vaccines is tempered by vaccine skepticism or hesitancy. If vaccine efficacy is 80%, then the herd immunity required from vaccination is about 75-90%. The aim of the current study was to study factors impacting COVID-19 vaccine hesitancy in a representative sample of adults (age≥18 years) in a COVID-19 hotspot
Identifiants
pubmed: 34242124
doi: 10.1080/21645515.2021.1948786
pmc: PMC8828105
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4013-4014Références
Ann Intern Med. 2020 Dec 15;173(12):964-973
pubmed: 32886525
J Public Health (Oxf). 2021 Sep 22;43(3):445-449
pubmed: 33367857
Lancet. 2020 Nov 21;396(10263):1614-1616
pubmed: 33159850
PLoS Negl Trop Dis. 2020 Dec 17;14(12):e0008961
pubmed: 33332359
J Ambul Care Manage. 2021 Jan/Mar;44(1):71-75
pubmed: 33165121
JAMA. 2020 Sep 15;324(11):1029-1030
pubmed: 32930764